Gland Pharma Gets EU GMP Nod

  Published 1 year ago

Gland Pharma’s Pashamylaram facility receives EU GMP certification from Denmark for aseptic powder injection, infusion, and inhalation.

  • Certification covers marketing authorizations for non-EEA manufacturers, boosting export prospects to European markets.
  • Facility approval enhances compliance credibility and supports growth in regulated markets.
  • Products include aseptically prepared powder for injection, infusion, and inhalation therapies.

You might like these

Jio Financial Services Shares Surge 4% on Broker Approval

Orient Electric Q2 Growth

Prestige Estates Q1 Sales Soar

Rupee Declines Amid Dollar Demand & Data

LT Foods Expands Organic Biz in Europe

Baazar Retail: Fire Losses, Claims in Review

India Forex Reserves Hit $703bn in One Week

News that matters the most ⚡